Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 3
1982 4
1983 6
1984 4
1985 1
1987 3
1988 3
1989 1
1990 1
1991 3
1992 3
1993 5
1994 2
1995 1
1996 4
1997 4
1998 2
2001 4
2002 3
2003 4
2004 7
2005 3
2006 8
2007 6
2008 5
2009 3
2010 6
2011 8
2012 6
2013 9
2014 3
2015 7
2016 7
2017 5
2018 5
2019 6
2020 8
2021 11
2022 14
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody.
Quijada H, Bermudez T, Kempf CL, Valera DG, Garcia AN, Camp SM, Song JH, Franco E, Burt JK, Sun B, Mascarenhas JB, Burns K, Gaber A, Oita RC, Reyes Hernon V, Barber C, Moreno-Vinasco L, Sun X, Cress AE, Martin D, Liu Z, Desai AA, Natarajan V, Jacobson JR, Dudek SM, Bime C, Sammani S, Garcia JGN. Quijada H, et al. Among authors: kempf cl. Eur Respir J. 2021 May 6;57(5):2002536. doi: 10.1183/13993003.02536-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33243842 Free PMC article.
Entry and uncoating of enveloped viruses.
Lanzrein M, Schlegel A, Kempf C. Lanzrein M, et al. Among authors: kempf c. Biochem J. 1994 Sep 1;302 ( Pt 2)(Pt 2):313-20. doi: 10.1042/bj3020313. Biochem J. 1994. PMID: 8092981 Free PMC article. Review. No abstract available.
Caplacizumab for relapsing thrombotic thrombocytopenic purpura.
Kaczmarek V, Holle J, Astudillo R, Kempf C, Bufler P, Müller D. Kaczmarek V, et al. Among authors: kempf c. Pediatr Nephrol. 2019 Sep;34(9):1625-1628. doi: 10.1007/s00467-019-04281-z. Epub 2019 Jun 8. Pediatr Nephrol. 2019. PMID: 31177334
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
Steelman LS, Franklin RA, Abrams SL, Chappell W, Kempf CR, Bäsecke J, Stivala F, Donia M, Fagone P, Nicoletti F, Libra M, Ruvolo P, Ruvolo V, Evangelisti C, Martelli AM, McCubrey JA. Steelman LS, et al. Among authors: kempf cr. Leukemia. 2011 Jul;25(7):1080-94. doi: 10.1038/leu.2011.66. Epub 2011 Apr 15. Leukemia. 2011. PMID: 21494257 Review.
Virus safety of intravenous immunoglobulin: future challenges.
Boschetti N, Stucki M, Späth PJ, Kempf C. Boschetti N, et al. Among authors: kempf c. Clin Rev Allergy Immunol. 2005 Dec;29(3):333-44. doi: 10.1385/CRIAI:29:3:333. Clin Rev Allergy Immunol. 2005. PMID: 16391410 Free PMC article. Review.
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.
McCubrey JA, Steelman LS, Kempf CR, Chappell WH, Abrams SL, Stivala F, Malaponte G, Nicoletti F, Libra M, Bäsecke J, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Cocco L, Martelli AM. McCubrey JA, et al. Among authors: kempf cr. J Cell Physiol. 2011 Nov;226(11):2762-81. doi: 10.1002/jcp.22647. J Cell Physiol. 2011. PMID: 21302297 Review.
Strengths and limitations of the model virus concept.
Käsermann F, Kempf C, Boschetti N. Käsermann F, et al. Among authors: kempf c. PDA J Pharm Sci Technol. 2004 Sep-Oct;58(5):244-9. PDA J Pharm Sci Technol. 2004. PMID: 15568644 Review.
Generation of Stable cisPt Resistant Lung Adenocarcinoma Cells.
Ruprecht N, Hofmann L, Hungerbühler MN, Kempf C, Heverhagen JT, von Tengg-Kobligk H. Ruprecht N, et al. Among authors: kempf c. Pharmaceuticals (Basel). 2020 May 29;13(6):109. doi: 10.3390/ph13060109. Pharmaceuticals (Basel). 2020. PMID: 32485798 Free PMC article.
177 results